Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Lifestance Health Group Inc (LFST)

  • Business News
  • Oct. 28, 2025, 20:10 UTC
  • 5
  • 0 comments

LifeStance to Present at the UBS Global Healthcare Conference

Market reaction Comment Full text

BrightSpring Health Services Inc. (BTSGU)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 4
  • 0 comments

BrightSpring Health Services, Inc. Reports Third Quarter 2025 Financial Results and Increases Full Year 2025 Guidance

Market reaction Comment Full text

Cumberland Pharmaceuticals Inc. (CPIX)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 4
  • 0 comments

CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q3 2025 FINANCIAL RESULTS & COMPANY UPDATE

Market reaction Comment Full text

Coherent Inc (COHR)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 4
  • 0 comments

Coherent Introduces Next-Generation Polarization-Maintaining Optical Fiber

Market reaction Comment Full text

IRIDEX Corporation (IRIX)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 4
  • 0 comments

Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025

Market reaction Comment Full text

Oil-Dri Corporation Of America (ODC)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 4
  • 0 comments

Oil-Dri to Host First Quarter 2026 Earnings Discussion and Fiscal Year 2025 Annual Meeting of Stockholders via Live Webcast

Market reaction Comment Full text

Vivani Medical Inc. (VANI)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 5
  • 0 comments

Vivani Medical, Inc. Announces Closing of Common Stock Offering

Market reaction Comment Full text

Arcus Biosciences Inc. (RCUS)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 4
  • 0 comments

Arcus Biosciences Reports Third-Quarter 2025 Financial Results and Provides a Pipeline Update

Market reaction Comment Full text

Tactile Systems Technology (TCMD)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 4
  • 0 comments

Landmark Study Demonstrates Sustained Clinical Benefits of Flexitouch® Plus as First-Line Therapy in Treating Head and Neck Cancer-Related Lymphedema

Market reaction Comment Full text

Ekso Bionics Holdings Inc (EKSO)

  • Business News
  • Oct. 28, 2025, 20:05 UTC
  • 3
  • 0 comments

Ekso Bionics Reports Third Quarter 2025 Financial Results

Market reaction Comment Full text
  • Previous
  • 49
  • 50
  • 51
  • 52
  • 53
  • Next

Search

News categories

  • Technical Exchange News(10321)
  • Event(1442)
  • SEC News(175325)
  • FDA Approval(9645)
  • Company Report(721)
  • Business News(117675)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin